title: Investigation of Mendelian forms of obesity holds out the prospect of personalized medicine.
abstract: Mendelian forms of obesity are already known to account for approximately 5% of the severely obese but are currently underinvestigated. In contrast, there has been much recent concentration on genome-wide single nucleotide polymorphism (SNP) associations in obesity, with particular emphasis given to the role of the fat mass and obesity associated (FTO) gene. Unfortunately, despite the enormous resources devoted to this work, none of the SNP markers in the ∼30 genes discovered to have associations with common obesity have meaningful predictive power. This is very different from the situation for Mendelian obesity, where mutations have very clear effects on phenotype. Study of Mendelian obesity has also added significantly to our understanding of mechanisms of appetite regulation, with all known causative genes being active in the brain and most forming part of the leptin-melanocortin signaling pathway. Investigation of genomic structural variation has also recently revealed deletions causing obesity, sometimes with concomitant neurocognitive dysfunction. Advances in next-generation sequencing are expected to uncover additional highly penetrant causes of obesity. Screening for Mendelian forms of obesity is rarely carried out but holds considerable promise for improved clinical care of these high-risk patients.
authors.affiliation: Department of Genomics of Common Disease, School of Public Health, Imperial College London, London, United Kingdom. a.blakemore@imperial.ac.uk
authors.forename: Alexandra I F
authors.initials: AI
authors.lastname: Blakemore
authors.forename: Philippe
authors.initials: P
authors.lastname: Froguel
mesh_terms: D000071516:Alpha-Ketoglutarate-Dependent Dioxygenase FTO; D006801:Humans; D020738:Leptin / Q000235:genetics / Q000378:metabolism; D053486:Melanocortins / Q000235:genetics / Q000378:metabolism; D009154:Mutation; D009765:Obesity / Q000235:genetics* / Q000378:metabolism / Q000628:therapy; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide; D057285:Precision Medicine / Q000379:methods; D011506:Proteins / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000235:genetics*
chemical_list: D020738:Leptin; D053486:Melanocortins; D011506:Proteins; D000071516:Alpha-Ketoglutarate-Dependent Dioxygenase FTO; C526492:FTO protein, human